Request for Covid-19 Impact Assessment of this Report
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The global Glucagon Like Peptide-1 (GLP-1) Agonists market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
Major applications as follows:
Hospital
Pharmacy
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Novo Nordisk
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 AstraZeneca
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Eli Lily
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 GSK
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Sanofi
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Bristol-Myers Squibb
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Amylin
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Hospital
4.1.1 Overview
4.1.2 Hospital Market Size and Forecast
4.2 Pharmacy
4.2.1 Overview
4.2.2 Pharmacy Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk
Tab Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lily
Tab Sales Revenue, Volume, Price, Cost and Margin of GSK
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Tab Sales Revenue, Volume, Price, Cost and Margin of Amylin
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2011-2017 (Value)
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2011-2017 (Volume)
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Value)
Fig Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Volume)
Fig Hospital Market Size and CAGR 2011-2017 (Value)
Fig Hospital Market Size and CAGR 2011-2017 (Volume)
Fig Hospital Market Forecast and CAGR 2018-2025 (Value)
Fig Hospital Market Forecast and CAGR 2018-2025 (Volume)
Fig Pharmacy Market Size and CAGR 2011-2017 (Value)
Fig Pharmacy Market Size and CAGR 2011-2017 (Volume)
Fig Pharmacy Market Forecast and CAGR 2018-2025 (Value)
Fig Pharmacy Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Value)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Value)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...